Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Robert J. Henning"'
Publikováno v:
Cell Transplantation, Vol 22 (2013)
We have previously demonstrated in acute myocardial infarctions that human umbilical cord blood mononuclear cells (HUCBCs), which contain hematopoietic, endothelial, and mesenchymal stem cells, reduce acute myocardial infarction size by ≥50% and pr
Externí odkaz:
https://doaj.org/article/000ebc16af104921bca7a28f553d86b7
Autor:
Robert J. Henning, Jose D. Burgos, Mark Vasko, Felipe Alvarado, Cyndy D. Sanberg, Paul R. Sanberg, Michael B. Morgan
Publikováno v:
Cell Transplantation, Vol 16 (2007)
There is no consensus regarding the optimal dose of stem cells or the optimal route of administration for the treatment of acute myocardial infarction. Bone marrow cells, containing hematopoietic and mesenchymal stem cells, in doses of 0.5 × 106 to
Externí odkaz:
https://doaj.org/article/95cefb63dfb142018fee90df97f96f0b
Autor:
Robert J. Henning M.D., Jose D. Burgos, Leo Ondrovic, Paul Sanberg, John Balis, Michael B. Morgan
Publikováno v:
Cell Transplantation, Vol 15 (2006)
We are investigating the effects of human umbilical cord blood mononuclear progenitor cells (HUCBC) for the treatment of acute myocardial infarction because human cord blood is a readily available and an abundant source of primitive cells that may be
Externí odkaz:
https://doaj.org/article/1ea03b20d2dd43fe87374d4ede829bdf
Autor:
Robert J. Henning M.D., Hamdi Abu-Ali, John U. Balis, Michael B. Morgan, Alison E. Willing, Paul R. Sanberg
Publikováno v:
Cell Transplantation, Vol 13 (2004)
Cell transplantation is a new treatment to improve cardiac function in hearts that have been damaged by myocardial infarction. We have investigated the use of human umbilical cord blood mononuclear progenitor cells (HUCBC) for the treatment of acute
Externí odkaz:
https://doaj.org/article/60d9591028644c65bfafc7ddf6d6d010
Publikováno v:
Cell Transplantation, Vol 12 (2003)
Externí odkaz:
https://doaj.org/article/3663744bd42747a9a0cbbf6901245534
Autor:
Robert J Henning
Publikováno v:
Future cardiology. 18(7)
Handheld 2D ultrasound devices (HUDs) have become available as an adjunct to physical examinations, visualizing the heart and lungs in real time and facilitating prompt patient diagnosis and treatment of cardiopulmonar.y disorders. These devices prov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2eaefb82e6d866fb286f9ed8dd68c31
https://pubmed.ncbi.nlm.nih.gov/35543226
https://pubmed.ncbi.nlm.nih.gov/35543226
Autor:
Robert J Henning
Publikováno v:
Future Cardiology. 16:317-342
Approximately 50 million adults worldwide have known congenital heart disease (CHD). Among the most common types of CHD defects in adults are atrial septal defects and ventricular septal defects followed by complex congenital heart lesions such as te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ae5c1e685bb1392e5dcbe5904e2c55
https://doi.org/10.2217/fca-2019-0061
https://doi.org/10.2217/fca-2019-0061
Autor:
Robert J Henning
Publikováno v:
Journal of Cardiovascular Translational Research. 14:195-212
Cardiac exosomes mediate cell-to-cell communication, stimulate or inhibit the activities of target cells, and affect myocardial hypertrophy, injury and infarction, ventricular remodeling, angiogenesis, and atherosclerosis. The exosomes that are relea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c4f2b98464010dbd6c9fc45fbc1cf2
https://doi.org/10.1007/s12265-020-10040-5
https://doi.org/10.1007/s12265-020-10040-5
Autor:
Robert J, Henning
Publikováno v:
Am J Cardiovasc Dis
Tricuspid regurgitation (TR) is present in 1.6 million individuals in the United States and 3.0 million people in Europe. Functional TR, the most common form of TR, is caused by cardiomyopathies, LV valve disease, or pulmonary disease. The five-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4793f7976b39f503cc50772d3fb86cdd
https://europepmc.org/articles/PMC8918740/
https://europepmc.org/articles/PMC8918740/
Autor:
Robert J Henning
Publikováno v:
Future Cardiology. 15:197-225
Heart disease is the leading cause of death among women in the industrialized world. However, women after myocardial infarctions (MIs) are less likely to receive preventive medications or revascularization and as many as 47% experience heart failure,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc96dd670d4da53800dfc5a4c45ca886
https://doi.org/10.2217/fca-2018-0079
https://doi.org/10.2217/fca-2018-0079